• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Arrien Pharmaceuticals

edit

Arrien Pharmaceuticals is a small molecule targeted therapeutics drug discovery and development company working towards targeting cell signaling pathways - A target class in treating neurodegenerative, Cancer, Inflammatory and Metabolic diseases. The Arrien is applying its proprietary platform to successfully discover a portfolio of uniquely identified pre-clinical stage programs in Parkinson’s, Alzheimer’s Diseases (PD, AD), Cancer, Rheumatoid Arthritis (RA), Type 2 Diabetes and Obesity diseases.

Recent Milestones

edit

• 
  Arrien Pharmaceuticals received $2M in Series A funding. (9/13/11)
  Posted 9/13/11 at 8:55pm via masshightech.com
• 
  Arrien Pharmaceuticals added Rajendra P. Appalaneni as Founder, Chairman & CEO.
  Posted 9/13/11 at 8:55pm

Videos

Screenshots

edit

Sources

1. Pharma startup Arrien raises $2M from founders (masshightech.com) [edit]